Publications and Presentations Database

Sort by: Author [ Title (Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
“
Uhlmann, W. R. (2012).  “The Swinging Gate: Genetic Testing and Ethical Issues,” .
Roberts, J. S., & Uhlmann, W. R. (2012).  “The REVEAL (Risk Evaluation and Education for Alzheimer’s Disease) Study,” .
T
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Cupples, L. A., et al. (2010).  Telephone and in-person disclosure of genetic test results: 6-week recall, comprehension, and distress among participants in the REVEAL Study.
P
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al. (2010).  The psychological impact of learning APOE ε4 increases the risk for cardiovascular disease during genetic risk assessment for Alzheimer’s disease: Findings from the REVEAL Study.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Royal, C. D. M., Obisesan, T., et al. (2010).  Perceived personal utility of Alzheimer’s disease genetic susceptibility testing and its influence on post-test responses: Findings from the REVEAL Study.
I
Gornick, M. C., Ryan, K. A., Scherer, A. M., Roberts, J. S., De Vries, R. G., & Uhlmann, W. R. (Submitted).  Interpretations of the term "actionable" when discussing genetic test results: What you mean is not what I heard. Journal of Genetic Counseling. Abstract
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al. (2009).  The Impact of Pleiotropic Information about Cardiovascular Disease Risk on Health Behavior Changes among People Seeking Genetic Susceptibility Testing for Alzheimer’s Disease: Initial Results from a Randomized Trial.
H
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al. (2010).  How does pleiotropic information affect health behavior changes? Initial results from the REVEAL Study, a randomized trial of genetic testing for Alzheimer’s disease.
G
Uhlmann, W. R. (2005).  Genetic Counseling and Ethical Issues.
E
Le, L. Q., Bartnik, N. J., Christensen, K. D., Uhlmann, W. R., Karlawish, J., Obisesan, T., et al. (2016).  Educating Patients and Care Partners about Mild Cognitive Impairment, APOE, and Alzheimer’s Disease: Findings from the REVEAL Study.
D
Hock, K. T., Christensen, K. D., Yashar, B. M., Roberts, J. S., Gollust, S. E., & Uhlmann, W. R. (2011).  Direct-to-consumer genetic testing: an assessment of genetic counselors' knowledge and beliefs. Genetics in medicine : official journal of the American College of Medical Genetics. 13(4), 325-32. Abstract
C
Szymaniak, J. M., Christensen, K. D., Uhlmann, W. R., Green, R. C., & Roberts, J. S. (2009).  A Condensed Genetic Counseling Approach for Alzheimer's Diseases Susceptibility Testing: What is the Psychological Impact? .
Roberts, J. S., Uhlmann, W. R., Petersen, R., Karlawish, J., & Green, R. C. (2009).  Clinical practices regarding Mild Cognitive Impairment (MCI) among neurology service providers.
B
Uhlmann, W. R. (2013).  Bioethics Grand Rounds: "The Swinging Gate: Genetic Testing and Ethical Issues".
Uhlmann, W. R. (2014).  Bioethics Grand Rounds: "Genetic Testing of Children for Adult-Onset Conditions: Ethical Considerations".